The mechanism of retrovirus suppression of human T cell proliferation in vitro
- PMID: 6311904
The mechanism of retrovirus suppression of human T cell proliferation in vitro
Abstract
Immunosuppression is commonly associated with retrovirus-induced animal tumors. Studies in the murine and feline retrovirus systems suggest that the 15,000-dalton envelope protein (p15E) of the virion may contribute to immunosuppression by interfering with normal lymphocyte function. We examined the effect of inactivated feline leukemia virus (UV-FeLV) and p15E derived from this virus on concanavalin A (Con A) driven human T cell proliferation. Virus and p15E markedly suppressed mononuclear cell proliferative response to Con A. Suppression was not due to inhibition of monocyte accessory cell function, or interleukin 1 (IL 1) secretion. In fact, the presence of monocytes partially protected T cells from UV-FeLV suppression. UV-FeLV, however, suppressed T cell secretion of and response to interleukin 2 (IL 2). We conclude that UV-FeLV and derived p15E inhibit T cell proliferation by direct inhibition of T cell function. These findings, extended to the in vivo situations, suggest that retrovirus-associated suppression of the immune response involves the induction of T cell but not monocyte dysfunction.
Similar articles
-
Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.J Immunol. 1985 May;134(5):3396-403. J Immunol. 1985. PMID: 2984289
-
Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.J Immunol. 1985 Jul;135(1):583-90. J Immunol. 1985. PMID: 2987350
-
Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus.Cancer Res. 1979 Mar;39(3):950-5. Cancer Res. 1979. PMID: 218725
-
Immunosuppressive actions of retroviruses.Lymphology. 1990 Jun;23(2):56-9. Lymphology. 1990. PMID: 2170777 Review.
-
Clinical and immunologic aspects of FeLV-induced immunosuppression.Vet Microbiol. 1988 Jul;17(3):287-96. doi: 10.1016/0378-1135(88)90070-3. Vet Microbiol. 1988. PMID: 2847393 Review.
Cited by
-
Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735.Cancer Immunol Immunother. 1985;19(2):90-100. doi: 10.1007/BF00199715. Cancer Immunol Immunother. 1985. PMID: 3157440 Free PMC article.
-
Type C retrovirus production by pancreatic beta cells. Association with accelerated pathogenesis in C3H-db/db ("Diabetes") mice.Am J Pathol. 1985 Apr;119(1):22-32. Am J Pathol. 1985. PMID: 2984941 Free PMC article.
-
Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1.Proc Natl Acad Sci U S A. 1989 Jan;86(2):621-5. doi: 10.1073/pnas.86.2.621. Proc Natl Acad Sci U S A. 1989. PMID: 2536171 Free PMC article.
-
Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.J Exp Med. 1985 Apr 1;161(4):766-84. doi: 10.1084/jem.161.4.766. J Exp Med. 1985. PMID: 2984305 Free PMC article.
-
Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.Drugs. 1987 Sep;34(3):372-90. doi: 10.2165/00003495-198734030-00004. Drugs. 1987. PMID: 2824170 Review.